Suppr超能文献

在初级干燥过程中采取强化条件,作为优化生物制药冷冻干燥周期的现代方法。

Aggressive conditions during primary drying as a contemporary approach to optimise freeze-drying cycles of biopharmaceuticals.

机构信息

Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia.

Lek d.d., Kolodvorska 27, 1234 Mengeš, Slovenia.

出版信息

Eur J Pharm Sci. 2018 Sep 15;122:292-302. doi: 10.1016/j.ejps.2018.07.016. Epub 2018 Jul 10.

Abstract

Freeze-drying is the method of choice to dry formulations with biopharmaceutical drugs, to enhance protein stability. This is usually done below the glass transition temperature of maximally freeze-concentrated solutions (T'), to avoid protein aggregation, preserve protein activity, and obtain pharmaceutically 'elegant' cakes. Unfortunately, this is a lengthy and energy-consuming process. However, it was recently shown that drying above T' or even above the collapse temperature (T) is not necessarily detrimental for stability of biopharmaceuticals, and hence provides an attractive option for freeze-drying cycle optimisation. The goal of the present study was to optimise the freeze-drying cycle for a model IgG monoclonal antibody (20 mg/mL) in sucrose and sucrose/glycine formulations, by reducing primary drying time. To study the impact of shelf temperature (T) and chamber pressure on product temperature (T), one conventional and five aggressive cycles were tested. Aggressive conditions during primary drying were achieved by increasing T from -20 °C (conventional cycle) to 30 °C, with chamber pressure set to 0.1 mbar, 0.2 mbar or 0.3 mbar. These combinations of T and chamber pressure resulted in T well above T', and in some cases, even above T, without causing macrocollapse. Other critical quality attributes of the products were also within the expected ranges, such as reconstitution time and residual water content. Physical stability was tested using size exclusion chromatography, dynamic light scattering, and micro-flow imaging. All of the lyophilised samples were exposed to stress and the intended storage conditions, with no impacts on the product seen. These data show that implementation of aggressive conditions for the investigated formulations is possible and can significantly contribute to the reduction of primary drying times by up to 54% (from 48 to 22 h) in comparison to conventional freeze-drying.

摘要

冷冻干燥是干燥生物制药配方的首选方法,以提高蛋白质稳定性。通常在最大冷冻浓缩溶液的玻璃化转变温度(T')以下进行,以避免蛋白质聚集,保持蛋白质活性,并获得药物学上“优雅”的块状物。不幸的是,这是一个冗长且耗能的过程。然而,最近的研究表明,在 T'以上甚至在坍塌温度(T)以上干燥对于生物制药的稳定性不一定有害,因此为冷冻干燥周期优化提供了有吸引力的选择。本研究的目的是通过减少初级干燥时间来优化模型 IgG 单克隆抗体(20mg/mL)在蔗糖和蔗糖/甘氨酸配方中的冷冻干燥周期。为了研究搁板温度(T)和腔室压力对产品温度(T)的影响,测试了一种常规和五种激进的循环。通过将 T 从-20°C(常规循环)升高到 30°C,同时将腔室压力设定为 0.1mbar、0.2mbar 或 0.3mbar,在初级干燥期间实现了激进条件。这些 T 和腔室压力的组合导致 T 远高于 T',在某些情况下,甚至高于 T',而不会导致大崩溃。产品的其他关键质量属性也在预期范围内,例如复溶时间和残留水分含量。使用尺寸排阻色谱、动态光散射和微流成像测试了产品的物理稳定性。所有冻干样品都暴露于应力和预期的储存条件下,产品没有受到影响。这些数据表明,对于所研究的配方,实施激进条件是可能的,并且可以通过将初级干燥时间缩短高达 54%(从 48 小时缩短至 22 小时)来显著贡献。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验